US Coverage

Law360 Authority | Deep News & Analysis

Global Coverage

Law360 Pulse | The Business of Law

Mealeys

MLex

November 22, 2023

Ipsen Biopharm Ltd et al v. Galderma Laboratories LP et al

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. January 03, 2024

    Galderma Labs Seeks OK Of Award Over Botox-Like Treatment

    Galderma Laboratories has asked a Texas federal court to enforce an arbitral award in its trade secrets dispute with Ipsen Biopharm over an application seeking U.S. government approval of a Botox-like treatment, saying the parties are bound by an International Chamber of Commerce arbitration.

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login